Glucose Metabolism Disorders Clinical Trials
2 recruiting trials for Glucose Metabolism Disorders. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Glucose Metabolism Disorders clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by KK Women's and Children's Hospital (1), University of Missouri-Columbia (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Wearable Care Group (device, 1 trial), followed by High animal protein isolate, High animal protein whole food.
Track Glucose Metabolism Disorders trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)
This study aims to test the following hypotheses in a randomized controlled trial of post-partum women with a history of gestational diabetes mellitus (GDM) that will be followed...
Animal and Plant Proteins and Glucose Metabolism
The goal of this proposal is to determine the effect of a high protein diet in which the increase in protein intake is derived from different sources (animal vs plant and...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Glucose Metabolism Disorders, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Glucose Metabolism Disorders, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Glucose Metabolism Disorders, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.